SAHPRA & Egyptian Drug Authority Forge New Partnership for Pharmaceutical Progress

Exciting news from Pretoria! The South Africa Health Products Regulatory Authority (SAHPRA) has inked a groundbreaking Memorandum of Understanding (MOU) with the Egyptian Drug Authority (EDA). This monumental alliance, signed at the Egyptian Embassy, promises to foster vital collaboration and engagement on mutual reliance for pharmaceuticals, biological products, and medical devices. 

This MOU marks the first of its kind between SAHPRA and a national regulatory authority in Africa, underlining our dedication to fostering collaboration and knowledge sharing with our African counterparts. The focus? Building capacity on the continent to ensure we stay rooted in regulatory processes. 

This partnership holds potential for setting a unified vision and coordinating effective dialogue between African countries in the pharmaceutical industries sector. 

The new partnership can remove barriers to trade, enhance people-to-people relations, and create a synergistic relationship where both regulators share knowledge and engage on areas of market authorization, pharmacovigilance, Good Manufacturing Practices (GMP) and clinical trials.